CellaVision Proficiency Software to be used for external quality assessment of hematology analyses.
CellaVision has signed an agreement with Equalis, the Swedish organization for external quality assurance of laboratory tests in health care. Equalis has chosen to invest in CellaVision new quality assurance program for differential counts of cells in blood and other body fluids, the CellaVision® Proficiency Software. The order includes a license for over 350 users which Equalis will incorporate during this year into their quality assessment program aimed at Sweden’s clinical-chemistry-focused medical laboratories.“
“With CellaVision Proficiency Software, we reach out easily to our scheme participants in hematology and can offer them a digital quality control tool that creates conditions for increased knowledge and more standardized test results, says Gunnar Nordin, President and Chief Medical Officer at Equalis. “One of the great benefits of the program, in addition to allowing us to easily distribute, monitor and follow up tests on-line, is that participants get instant feedback on their performance in form of valuable statistics. The program is both a testing tool and a source to increase knowledge. ”
Gunnar Nordin, Equalis
Equalis is a Swedish not-for-profit organization that provides external quality assessment of clinical laboratory investigations. It is accredited by Swedac as a provider of interlaboratory comparisons in laboratory medicine (ISO/IEC 17043) and is co-owned by the Swedish Association of Local Authorities and Regions, the Swedish Society for Medicine, and the Swedish Institute of Biomedical Laboratory Science. Now Equalis will incorporate the CellaVision Proficiency Software in its quality assessment program for hematology analyses.
According to the agreement with Equalis, CellaVision will supply 350 user licenses for the CellaVision Proficiency Software, which Equalis will incorporate during this year into their quality assessment program aimed at Sweden’s clinical-chemistry-focused medical laboratories.
More information click on link below
Great interest and many good comments on this case!
His diagnosis was: Eosinophilic meningitis secondary to Angiostrongylus cantonensis infection. Angiostrongylus cantonensis is a parasitic nematode (roundworm) which causes angiostrongyliasis, the most common cause of eosinophilic meningitis in Southeast Asia and the Pacific Basin. The nematode commonly resides in the pulmonary arteries of rats, giving it the nickname rat lungworm.
Humans are incidental hosts of this roundworm, and may become infected through the ingestion of larvae in raw or undercooked seafood or other vectors, or from contact with contaminated water or vegetables. The larvae are then transported via the blood to the central nervous system, where they are the most common cause of this type of meningitis — a serious condition that can lead to death or permanent brain and nerve damage, and that is characterized by a high eosinophil percentage.
Do you have an intersting case to share? Please contact us at email@example.com
Who can tell the diagnosis?
A 50-year-old male from the State of Nevada was sailing his boat in the South Pacific for over a month. He would frequently eat raw shellfish and raw fish. He presented to a hospital in Nevada with muscle pain, numbness and headache.
A spinal fluid aspiration was done and the sample was prepared via cytospin run on a
CellaVision® DM96 with the Body Fluid Application.
Total nucleated cell count of the spinal fluid: 815 × 10-6/Liter.
Differential white cell count:
Please share your suggested diagnosis!
Microscopic images of the spinal fluid:
We continually strive to improve customer satisfaction by listening to you and taking your valuable feedback into account when improving our products and services. We have now, for the third year in a row, conducted our annual Customer Satisfaction Survey in which we ask the CellaVision customers about their experiences.
The 2012 survey was carried out during a 2-week period at the end of February and beginning of March. The response rate was very high and we are very grateful to all of you who took part and provided us with valuable information on how you use our products and what features you would be interested in seeing developed.
To show our appreciation, we held a prize draw for all survey participants, and the winner this year was from Norway.
Congratulations to the winner and thanks to all of you who took part in this survey!
CellaVision releases a new powerful web-based program for proficiency testing of blood and body-fluid differentials!
Make CellaVision® Proficiency Software part of your lab’s routines and see how easy it can be to conduct proficiency testing while saving valuable time and resources.
The CellaVision Proficiency Software is quick to set up and easy to use. The program can be accessed from any computer and any location. Simply open a web browser and log in to your account.
Slides, CBC data, scatterplots and other patient data can be uploaded from multiple locations to one shared account and used to create proficiency tests. Once completed, test results are automatically generated, providing the test group with instant feedback to promote independent learning. Discover how in this interactive workflow diagram.
- Internal and external quality assurance
- For peripheral blood and body fluids
- Clear, automatic result reporting
- Standardize differntials
- Improve morphology expertise
- Ensure quality throughout the organisation
Now you can create your free trial account at www.cellavision-proficiency.com
Or sign up to participate in our global test experiment and interact with your peers!